Palantir Technologies Inc. enters the week navigating significant regulatory turbulence after the U.S. Department of Defense moved to restrict a key artificial intelligence supplier, casting uncertainty over the company's defense-contracting business. The stock closed Friday's session at $157.16, having weathered a volatile trading day that saw it swing between $150.29 and $161.45 as investors digested the news.
Pentagon Crackdown Targets AI Supply Chain
On Thursday, the Pentagon formally labeled AI lab Anthropic as a "supply-chain risk," a designation that effectively prohibits government contractors from utilizing its technology in U.S. military projects. This policy shift immediately raised questions about defense software providers, notably Palantir, whose Maven Smart Systems platform for intelligence and targeting reportedly relies on Anthropic's Claude AI codebase.
The implications are substantial. Contractors like Palantir may now be forced to overhaul critical software systems, seek alternative AI models, or obtain special government exemptions—a process with an unclear timeline. The situation intensified early Saturday when the Financial Times reported the administration is pushing for stricter requirements on civilian AI contracts, demanding companies permit "any lawful" use of their models.
Government Contracts Unravel
Adding to the disruption, the U.S. General Services Administration terminated its contract with Anthropic for the OneGov platform. A GSA official stated it would be "irresponsible" and "dangerous" to continue the partnership. In a contrasting move, Microsoft announced that, following a legal review, it would continue offering Anthropic's technology via its platforms to customers outside the Pentagon's purview.
Anthropic has signaled it will legally challenge the Pentagon's designation. CEO Dario Amodei confirmed the company received the risk notification letter and sees "no choice but to challenge it in court." This potential legal battle threatens to create a prolonged period of uncertainty for contractors and customers, complicating deployment timelines beyond mere technical adjustments.
Broader Market Jitters Add Pressure
The Palantir-specific concerns unfold against a backdrop of wider market anxiety. U.S. equities declined on Friday as oil prices surged 12% and February payrolls data showed an unexpected drop. This combination has sparked fresh stagflation worries, complicating the Federal Reserve's path toward interest rate cuts. "It raises the question of whether the Fed will even be able to cut rates," remarked Kristina Hooper, chief market strategist at Man Group.
Analysts at Goldman Sachs have warned that crude oil could surge past $100 per barrel as soon as next week if traffic through the critical Strait of Hormuz fails to rebound, a scenario that would sustain upward pressure on interest rates and ripple through risk-sensitive assets like technology stocks.
Key Data and Guidance on the Horizon
Investors are awaiting two critical updates this week. First, the market seeks clarification from the Pentagon on how the Anthropic ban will be implemented for existing contracts. The central question is whether systems require immediate modification or if transition plans will allow continued operation in the near term.
Second, macroeconomic forces will be in focus with the release of the U.S. Consumer Price Index for February on Wednesday, March 11, at 8:30 a.m. ET. This inflation report is known to heavily influence Treasury yields and the valuation of high-growth software stocks, including Palantir.
Palantir heads into this period having recently posted gains, but now contends with a fundamental challenge to its defense technology stack: determining which AI models power its tools and securing Washington's approval for their use by government contractors. The company's ability to manage this regulatory pivot will be closely watched by the investment community.
